Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bimatoprost

Known as: 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-, Bimatoprost [Chemical/Ingredient], Bimatoprostum 
A synthetic prostamide and structural prostaglandin analogue with ocular hypotensive activity. Bimatoprost mimics the effects of the endogenous… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
TOPIC Primary open-angle glaucoma (POAG) is a highly prevalent condition worldwide and the most common cause of irreversible… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE To describe periorbital changes induced by chronic topical therapy with daily bimatoprost 0.03% (Lumigan, Allergan Inc… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE To study the effects of 3 prostaglandin analogs, bimatoprost, latanoprost, and travoprost, on aqueous dynamics in the… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Conjunctiva-derived epithelial cells were used to investigate, in vitro, the expression of various inflammation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To estimate the intraocular pressure (IOP) reduction achieved by the most frequently prescribed glaucoma drugs and a… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE To report a new adverse effect related to treatment with bimatoprost. CASE REPORTS Serial clinical examination of three… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To Internet Advance publication at ajo.com Feb 13, 2003. compare the intraocular pressure (IOP)-lowering effect and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE To compare the intraocular pressure (IOP)-lowering efficacy and safety of topical bimatoprost 0.03% with latanoprost 0… Expand
Is this relevant?
Review
2001
Review
2001
Bimatoprost (Lumigan) is a pharmacologically unique and highly efficacious ocular hypotensive agent. It appears to mimic the… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The efficacy and safety of bimatoprost, a member of a new class of pharmacological agents called prostamides, were compared with… Expand
Is this relevant?